Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 2
1974 1
1983 1
1986 1
1987 2
1988 1
1989 1
1990 2
1991 3
1992 2
1993 4
1994 1
1995 3
1996 2
1997 2
1998 3
1999 6
2000 4
2001 7
2002 4
2003 11
2004 10
2005 18
2006 18
2007 16
2008 11
2009 14
2010 23
2011 31
2012 43
2013 39
2014 43
2015 42
2016 42
2017 44
2018 38
2019 50
2020 58
2021 62
2022 47
2023 42
2024 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

692 results

Results by year

Filters applied: . Clear all
Page 1
Endometrial cancer.
Makker V, MacKay H, Ray-Coquard I, Levine DA, Westin SN, Aoki D, Oaknin A. Makker V, et al. Among authors: aoki d. Nat Rev Dis Primers. 2021 Dec 9;7(1):88. doi: 10.1038/s41572-021-00324-8. Nat Rev Dis Primers. 2021. PMID: 34887451 Free PMC article. Review.
Cancer of the cervix uteri: 2021 update.
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Bhatla N, et al. Among authors: aoki d. Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):28-44. doi: 10.1002/ijgo.13865. Int J Gynaecol Obstet. 2021. PMID: 34669203 Free PMC article.
Cancer of the cervix uteri.
Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Bhatla N, et al. Among authors: aoki d. Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:22-36. doi: 10.1002/ijgo.12611. Int J Gynaecol Obstet. 2018. PMID: 30306584
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial.
Monk BJ, Toita T, Wu X, Vázquez Limón JC, Tarnawski R, Mandai M, Shapira-Frommer R, Mahantshetty U, Del Pilar Estevez-Diz M, Zhou Q, Limaye S, Godinez FJR, Oppermann Kussler C, Varga S, Valdiviezo N, Aoki D, Leiva M, Lee JY, Sulay R, Kreynina Y, Cheng WF, Rey F, Rong Y, Ke G, Wildsmith S, Lloyd A, Dry H, Tablante Nunes A, Mayadev J. Monk BJ, et al. Among authors: aoki d. Lancet Oncol. 2023 Dec;24(12):1334-1348. doi: 10.1016/S1470-2045(23)00479-5. Lancet Oncol. 2023. PMID: 38039991 Clinical Trial.
Ovarian cancer.
Song YS, Kim HS, Aoki D, Dhanasekaran DN, Tsang BK. Song YS, et al. Among authors: aoki d. Biomed Res Int. 2014;2014:764323. doi: 10.1155/2014/764323. Epub 2014 Dec 21. Biomed Res Int. 2014. PMID: 25587539 Free PMC article. No abstract available.
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).
Hamanishi J, Takeshima N, Katsumata N, Ushijima K, Kimura T, Takeuchi S, Matsumoto K, Ito K, Mandai M, Nakai H, Sakuragi N, Watari H, Takahashi N, Kato H, Hasegawa K, Yonemori K, Mizuno M, Takehara K, Niikura H, Sawasaki T, Nakao S, Saito T, Enomoto T, Nagase S, Suzuki N, Matsumoto T, Kondo E, Sonoda K, Aihara S, Aoki Y, Okamoto A, Takano H, Kobayashi H, Kato H, Terai Y, Takazawa A, Takahashi Y, Namba Y, Aoki D, Fujiwara K, Sugiyama T, Konishi I. Hamanishi J, et al. Among authors: aoki d. J Clin Oncol. 2021 Nov 20;39(33):3671-3681. doi: 10.1200/JCO.21.00334. Epub 2021 Sep 2. J Clin Oncol. 2021. PMID: 34473544 Free PMC article. Clinical Trial.
Mechanochromic cyclodextrins.
Sugita Y, Aoki D, Tokita M, Otsuka H. Sugita Y, et al. Among authors: aoki d. Chem Commun (Camb). 2022 Mar 1;58(18):3067-3070. doi: 10.1039/d2cc00363e. Chem Commun (Camb). 2022. PMID: 35166758
Unconventional superconductivity in UTe2.
Aoki D, Brison JP, Flouquet J, Ishida K, Knebel G, Tokunaga Y, Yanase Y. Aoki D, et al. J Phys Condens Matter. 2022 Apr 13;34(24). doi: 10.1088/1361-648X/ac5863. J Phys Condens Matter. 2022. PMID: 35203074 Review.
Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical Trial.
Nomura H, Aoki D, Michimae H, Mizuno M, Nakai H, Arai M, Sasagawa M, Ushijima K, Sugiyama T, Saito M, Tokunaga H, Matoda M, Nakanishi T, Watanabe Y, Takahashi F, Saito T, Yaegashi N; Japanese Gynecologic Oncology Group. Nomura H, et al. Among authors: aoki d. JAMA Oncol. 2019 Jun 1;5(6):833-840. doi: 10.1001/jamaoncol.2019.0001. JAMA Oncol. 2019. PMID: 30896757 Free PMC article. Clinical Trial.
692 results